GENEOS THERAPEUTICS
Geneos is developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment. The company's technology is designed to identify relevant neoantigen targets from individual patient tumors to develop novel treatments for cancer, providing patients with tumor targeted immunotherapies to cure their disease.
GENEOS THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2016-08-01
Address:
Plymouth Meeting, Pennsylvania, United States
Country:
United States
Website Url:
http://www.geneostx.com
Total Employee:
1+
Status:
Active
Total Funding:
39.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Acylin Therapeutics
Acylin Therapeutics operates in the pharmaceutical and drug manufacturing industry developing inhibitors of cellular acetylation.
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Atom Bioworks
Atom Bioworks is a developer of a pattern-recognition enabled sensing and therapeutics platform designed to help in medical.
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Dignify Therapeutics
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Dracen Pharmaceuticals
Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.
Edifice Health
Edifice Health is a immunological health and personalized nutrition company offering a novel metric of inflammatory health.
GenFleet Therapeutics
GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.
Hale Therapeutics
Hale Therapeutics, a Philadelphia firm developing a nicotine vaporizer designed to wean smokers and vapers off of nicotine.
Hoba Therapeutics
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Manifold Bio
Manifold Bio is building a protein barcoding platform to bring the power of multiplexed measurement.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
MDI Therapeutics
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
VYNE Therapeutics
VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.
Mimosa Therapeutics
Mimosa Therapeutics is a biotech company that offers research-grade natural products and drug potency test kits.
Nivien Therapeutics
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Opsonix
Opsonix is a developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis.
Oxford Vacmedix
Develop therapeutic agents for the treatment of cancer .
Palleon Pharmaceuticals
Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.
PDC*line Pharma
PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells.
Pear Therapeutics
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PolyProx
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Providence Therapeutics
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
PuREC
PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Qool Therapeutics
Qool Therapeutics is dedicated to creating non-invasive, efficient temperature management therapies to preserve cells.
Repare Therapeutics
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Rodeo Therapeutics
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Skyhawk Therapeutics
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.
Stellanova Therapeutics
Stellanova Therapeutics is a private, development-stage biotechnology company that focuses on cancer therapies
Stemgenics
Stemgenics is a developer of a technology that converts mature skin cells into personalized stem cells.
USMD
USMD Holdings develops, operates and manages entities that deliver diagnostic, therapeutic and hospital-based health care to patients.
Westlake Therapeutics
The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.
ZY Therapeutics
ZY Therapeutics develops a drug delivery platform for cancer therapeutics using nanotechnology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Global Bio Fund
Global Bio Fund investment in Series A - Geneos Therapeutics
Flerie Invest
Flerie Invest investment in Series A - Geneos Therapeutics
Sante Ventures
Sante Ventures investment in Series A - Geneos Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Series A - Geneos Therapeutics
Inovio Pharmaceuticals
Inovio Pharmaceuticals investment in Series A - Geneos Therapeutics
Sante Ventures
Sante Ventures investment in Series A - Geneos Therapeutics
Inovio Pharmaceuticals
Inovio Pharmaceuticals investment in Series A - Geneos Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Series A - Geneos Therapeutics
Sante Ventures
Sante Ventures investment in Series A - Geneos Therapeutics
Inovio Pharmaceuticals
Inovio Pharmaceuticals investment in Series A - Geneos Therapeutics
Official Site Inspections
http://www.geneostx.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: al-web-pro-02.aplusl.io
- IP address: 3.214.35.33
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Geneos Therapeutics"
Team Archive - Geneos Therapeutics
Joann Peters joined Geneos after a successful 19-year career working in the Contract Research Organization (CRO) industry where she supported the growth strategy of companies and effectively led oncology focused study teams.See details»
Management - Geneos Therapeutics
Myrna Thomas brings over 25 years of Quality and Manufacturing experience to Geneos. During her career, she has provided broad US and European experience in Quality Assurance, …See details»
Geneos Therapeutics - Crunchbase Company Profile & Funding
Geneos is developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment. The company's technology is designed to identify relevant neoantigen …See details»
Geneos Therapeutics - LinkedIn
Geneos Therapeutics | 2,067 followers on LinkedIn. Developing the next generation of patient specific neoantigen-targeting cancer immunotherapies, one patient at a time. | At Geneos, our passion ...See details»
GENEOS THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GENEOS THERAPEUTICS, INC. of Plymouth Meeting, PA. Get the latest business insights from Dun & …See details»
Geneos Therapeutics Company Overview, Contact Details
Oct 11, 2022 | www.geneostx.com. Geneos Therapeutics receives financing of $17M in Series A2. Financing led by Flerie Invest and Dr. Ted Fjällman joins Geneos’ Board of Directors …See details»
Geneos Therapeutics - Craft
Geneos Therapeutics has 1 employees at their 1 location and $22.5 m in total funding,. See insights on Geneos Therapeutics including office locations, competitors, revenue, financials, …See details»
Geneos Therapeutics - workinbiotech.com
Founded: 2019 Location: Plymouth Meeting, PA Employee range: 1 - 10 Clinical stage: Clin2 Therapy area: Hepatocellular carcinoma Drug types: ONC Lead product: GT-30 Funding: $5M …See details»
Geneos Therapeutics - Overview, News & Similar companies
View Geneos Therapeutics (www.geneostx.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Geneos Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Www.geneostx.com. Startups | Holding Company | 2016 | Pennsylvania, United States | < 10 | www.geneostx.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational …See details»
CORPORATE OVERVIEW 1Q 2021 - Geneos Therapeutics
Mar 4, 2021 8 • Mutations and other somatic changes in the tumor (cancer neoantigens)are recognized by the immune system as “foreign” to mount an immune response against the …See details»
Geneos Therapeutics (USA) Funding: $49.5M - Medical Startups
Jan 9, 2025 Geneos is developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. These mutations form during …See details»
Geneos Therapeutics - VentureRadar
Similar Companies: Gritstone Oncology USA Privately Held Gritstone Oncology is a privately-held, next-generation personalized cancer immunotherapy company. Gritstone brings together …See details»
VGXI and Geneos Therapeutics Expand Partnership for …
Mar 16, 2021 Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical Manufacturing Supply Agreement in Support of Geneos’ Ongoing GT-30 …See details»
Exquisitely personalized cancer immunotherapies - Nature
Www.geneostx.com Exquisitely personalized cancer immunotherapies Pennsylvania-based Geneos Therapeutics is using its clinically validated GT-EPIC platform to generate cancer …See details»
Privacy Policy - Geneos Therapeutics
Dec 2, 2020 By email: [email protected]; By mail: 660 West Germantown Pike LL100, Plymouth Meeting PA 19462; Only You, or a person registered with the California Secretary of …See details»
Personalized Neoantigen Vaccine Induces Continued Responses in ...
Aug 22, 2023 Second-line treatment with GNOS-PV02 plus plasmid-encoded interleukin-12 followed by electroporation elicited complete molecular response detected via circulating …See details»
GeneDx CEO wants genetic testing for every newborn | AP News
1 day ago The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, …See details»
Immediate Release Geneos Therapeutics Secures $12 Million in …
Mar 3, 2021 www.geneostx.com . About Geneos Therapeutics . At Geneos Therapeutics, we believe that personalized therapies are the future of cancer treatment. Our passion is to …See details»
VGXI and Geneos Therapeutics Expand Partnership for Personalized
Mar 16, 2021 Page3/3 Ifyouhaveanyquestionsregardinginformationinthesepressreleasespleasecontactthecompanylistedinthepressrelease.Ourcompletedisclaimer …See details»